Michael James Gagliardo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 West Brook Dr, Clifton Heights, PA 19018 Phone: 610-623-0600 Fax: 610-623-0970 |
News Archive
Roche has announced that its new test for detection of Chlamydia trachomatis has received CE Mark certification, allowing it to be sold for clinical use in the European Union.
The New York Times examines an HIV prevention program in China aimed at promoting blood screening that has led "more than 110,000 people" to be tested so far: "On any given night, in 14 cities around the country, hundreds of people flock to makeshift blood collection centers in bars, bathhouses and apartments where workers test for syphilis and HIV, the virus that causes AIDS."
The brothers of men with prostate cancer are at an increased risk of prostate cancer diagnosis because of increased diagnostic activity and not necessarily because they carry a genetic mutation that increases risk of the disease, according to a study published online August 19 in The Journal of the National Cancer Institute.
Researchers from the University of São Paulo in Brazil have developed a strategy for treating the most aggressive type of brain cancer in adults that combines a photoactive molecule and a chemotherapeutic agent - both encapsulated in protein-lipid nanoparticles.
Doctors from the Mayo Clinic in Jacksonville, Florida showcased positive results of peripheral nerve stimulation (PNS) in a patient suffering from post-herpetic neuralgia (PHN), or pain after a herpes breakout.
› Verified 9 days ago